Table 4: Antimicrobial activity of the component #1 of the B. subtilis 534 antibacterial complex against clinical isolates of K. pneumoniae.
| Clinical isolates, ## | Growth inhibition zones, mm | The susceptibility/resistance of clinical isolates against 24-28 medical antibiotics* | |||||
| CL | Component #1 | R | I | S | Details:** | ||
| 320 | 0 | 0 | 19 | 1 | 6 | 6S: FOX, IPM, MEM, TGC, PMB, CL 1I: TE | |
| 634 | 0 | 0 | 17 | 1 | 8 | 8S: AN, FOX, IPM, MEM, LVX, TGC, PMB, CL 1I: CIP | |
| 692 | 0 | 0 | 20 | 1 | 7 | 7S: AN, FOX, ETP, IPM, MEM, PMB, CL 1I: TGC | |
| 775 | 0 | 0 | 16 | 1 | 9 | 9S: AN, GM, IPM, MEM, TE, TGC, SXT, PMB, CL 1I: FOX | |
| 821 | 0 | 11 | 23 | 0 | 3 | 3S: TGC, PMB, CL | |
| 1050 | 0 | 0 | 17 | 2 | 5 | 5S: AN, GM, IPM, PMB, CL 2I: TGC, NN | |
| 1054 | 0 | (11)** | 19 | 1 | 4 | 4S: FOX, IPM, MEM, TGC 1I: LVX | |
| 1071 | 0 | (9)** | 20 | 0 | 4 | 4S: ATM, FEP, CAZ, CRO | |
| 1074 | 0 | (11)** | 23 | 23 | 0 | 3I: PIP/TAZ, PMB, CL | |
| 1114 | Trace*** | 7 | 20 | 2 | 4 | 4S: AN, GM, PMB, CL 2I: TGC, NN | |
| 1878 | 0 | 8 | 23 | 1 | 0 | 1I: TGC | |
| 2080 | Trace*** | Trace*** | 23 | 1 | 0 | 1I: TGC | |
| 2266 | 0 | 0 | 23 | 0 | 3 | 3S: CAZ, TGC, PMB | |
| 2427 | 0 | 0 | 23 | 0 | 2 | 2S: TGC, PMB | |
| 2663 | 0 | 0 | 23 | 0 | 2 | 2S: TGC, PMB | |
| 3168 | - | (9)** | 22 | 1 | 3 | 3S: TGC, PMB, CL 1I: TE | |
| 3186 | - | 0 | 23 | 0 | 3 | 3S: TGC, PMB, CL | |
| 3266 | - | 0 | 22 | 0 | 4 | 4S: CIP, LVX, PMB, CL | |
| 4095 | - | (8)** | 23 | 1 | 2 | 2S: PMB, CL 1I: TGC | |
| 4261 | - | 0 | 19 | 0 | 7 | 7S: ATM, FEP, CAZ, CIP, LVX, PMB, CL | |
| 4353 | - | 0 | 14 | 1 | 11 | 11S: ATM, FEP, CTX, CAZ, CRO, IPM, MEM, CIP, LVX, PMB, CL 1I: TGC | |
| 4375 | 0 | 0 | 17 | 0 | 8 | 8S: AN, ETP, GM, IPM, MEM, TGC, PMB, CL | |
*Antibiotics: AN: Amikacin; ATM: Aztreonam; C: Chloramphenicol; CAZ: Ceftazidime; CIP: Ciprofloxacin; CL: Colistin; CRO: Ceftriaxone; CTX: Cefotaxime; E: Erythromycin; ETP: Ertapenem; FEP: Cefepime; FOX: Cefoxitin; GM: Gentamicin; IPM: Imipenem; LVX: Levofloxacin; MEM: Meropenem; MXF: Moxifloxacin; NN: Tobramycin; OX: Oxacillin; P: Penicillin; PIP: Piperacillin; PIP/TAZ: Piperacillin/Tazobactam; PMB: Polymyxin B; RA: Rifampin; SXT: Trimethoprim/Sulfamethoxazole; TE: Tetracycline; TGC: Tigecycline; R: Resistance; I: Intermediate susceptibility; S: Susceptibility.
**- Growth oppression.
***"Trace" - The thickness of the ring of the growth inhibition zone around the hole in agar medium with the sample which is tested for antimicrobial activity does not exceed 1 mm.